BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
about
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersAnalysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesMyriad Genetics: In the eye of the policy stormHereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.PALB2 variants in hereditary and unselected Finnish prostate cancer cases.Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer.Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites.Current and future systemic treatment options in metastatic pancreatic cancer.Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control studyDistinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors.A novel in vitro pancreatic carcinogenesis model.Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.Helicobacter pylori activation of PARP-1: usurping a versatile regulator of host cellular healthThe Fanconi anemia pathway and ICL repair: implications for cancer therapy.Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential associationGenomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary.Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.Familial gastric cancer: detection of a hereditary cause helps to understand its etiology.Cell type-specific properties and environment shape tissue specificity of cancer genes.Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling studyLoss of BRCA1 expression leads to worse survival in patients with gastric carcinomaMultiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes.Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the MutationThe contribution of BRCA1 and BRCA2 to ovarian cancer.Response of BRCA1-mutated gallbladder cancer to olaparib: A case report.Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.Deubiquitylating enzymes and DNA damage response pathways.Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer.KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer.Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study.Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.Gastric Adenocarcinoma: A Multimodal Approach.Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis.
P2860
Q21260410-50279A2A-3AE7-41DA-BBC3-06673CDE02E4Q24170413-21F1921C-496E-4B95-9A5F-FDB9D6508E4FQ28742896-A80C99F2-F3B8-4EB7-B04C-FE71E641A32DQ30652890-89CF63C3-425C-4C02-B596-4880B86E1D65Q33590262-01CE7F0D-1109-4061-BBB3-09C64E1CD6D8Q33622362-7D32E9C9-D71A-40CA-A77A-1F9D56CF39C9Q33730640-57A67FEB-A224-4254-AD5A-7E42B0E3C66CQ33948033-12903CD6-8F41-4DB4-AA5F-B20A270E8072Q34208198-B7CCC1E4-0826-46B7-9F00-0765C60E1F8AQ34416049-71D8E737-C6C8-4BFF-99F7-7276488A76D0Q34641046-7152B464-A445-4A1E-80A2-B338707586EEQ34663583-A42E42C6-B9A9-483D-8441-BFDC56B1A51CQ34664112-B9B4CEDE-365F-462C-89B7-A984268F0362Q35024542-D3319EA6-74FF-42EE-BBBF-799931804B86Q35038084-83C1873B-DEDE-4DF2-9557-B13879232444Q35823594-DC7C86B0-C10A-466F-9314-45E930D11BF8Q36144711-63A441CA-D9D2-4E20-8660-B30B2FC12C54Q36252996-111A0A8B-5622-44CD-8470-3614A919E813Q36310189-55E54F00-6DDE-4ECC-AD30-34256011428AQ36385670-5675114D-A28C-47DC-BE67-1D28D13BBBD1Q36466697-F7ACFA3D-86C5-4D54-B223-003B64BD6D36Q36541982-20834933-51DF-44E8-8DC1-46B59961DB7DQ36559901-119937FB-807C-478F-A408-0B5E97B4E97EQ36718976-98498758-9AA7-42EC-9922-5AF87B3DF1C1Q36731204-EB11EB7A-99B5-4AC8-AF9C-801B31F36CFDQ36926475-CE777AC1-A650-466F-BE24-16D576600999Q37085786-7C9D7FBB-A4F2-44E8-8F52-DE505B8D5F7AQ37231035-74A13B84-4D8D-4138-98A2-4A2A09D88B14Q37240051-6C288CC6-BE2C-485B-914D-E647E08EB8AFQ37453854-EA5A00EC-5D5B-4F6A-A321-E6314A031403Q37501085-BBF35972-8214-4A2B-BAD4-15C676E2D692Q37709387-6D3E0D9E-0AE2-4C35-8CFC-B53D3CB14CF3Q38109871-14038DE3-0243-4B09-A26C-1D002B3F596EQ38938253-3A965B7C-CC5C-4C7B-93E6-83DD1DC4B0B5Q39269556-9ACA3846-CEE3-48C9-BC02-1942A071BCEEQ39699084-FCB6A840-7939-496B-821C-2C9FEB34AE3EQ40044373-FE06E5AA-999A-4E12-BC18-8AF06F85F5D2Q40134731-20986511-43B0-4D97-AE8E-B0FD8A3B0532Q41221377-894754B6-4C23-4C99-AE68-89CA9DA9F476Q41238734-E011F52F-DB07-492F-8840-D07050EA53C3
P2860
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@ast
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@en
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@nl
type
label
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@ast
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@en
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@nl
prefLabel
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@ast
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@en
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@nl
P2860
P1476
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
@en
P2093
Bernard Friedenson
P2860
P407
P577
2005-01-01T00:00:00Z